论文部分内容阅读
时间刚刚踏入2008年,全国科技奖励大会在人民大会堂举行。以岭药业与清华大学联合完成的国家高技术发展计划项目“虫类药超微粉碎(微米)技术及应用”荣获国家技术发明二等奖,这是运用该技术生产的主导药物“通心络胶囊”第三次获得国家科技大奖。在2000年,因配方、实验和临床研究的创新性,“通心络胶囊治疗冠心病的研究”获得国家科技进步二等奖。2006年,指导通心络胶囊研发的“络病理论及其应用研究”获得国家科技进步二等奖。这次获得国家技术发明奖,是因为通心络胶囊制备工艺技术的创新性。
Just entered the time in 2008, the National Science and Technology Awards Conference was held in the Great Hall of the People. Yiling Pharmaceutical and Tsinghua University jointly completed the national high-tech development project “insecticide ultrafine crushing (micron) technology and application ” won the second prize of national technology invention, which is the use of the technology to produce the leading drug “Tongxinluo Capsule” won the National Science and Technology Award for the third time. In 2000, due to the innovativeness of formulating, experiment and clinical research, “Tongxinluo Capsule Research on Coronary Heart Disease” won the second prize of National Science and Technology Progress Award. In 2006, “Tongzhi Theory and Applied Research”, which guides the research and development of Tongxinluo Capsule, won the second prize of national science and technology progress. This won the National Technology Invention Award, because Tongxinluo Capsule preparation technology innovation.